Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–68.
Article
PubMed
Google Scholar
Lembke A. Why doctors prescribe opioids to known opioid abusers. N Engl J Med. 2012;367(17):1580–1.
Article
PubMed
CAS
Google Scholar
Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007;16(8):827–40.
Article
PubMed
CAS
Google Scholar
Cohen H, Webb T. During 2011–2015, 3,601 people died from an opioid-related overdose – a nearly twofold increase from 2001–2005: ABC News; 2017. Available at: http://www.abc.net.au/news/2017-11-24/deaths-from-prescription-drug-fentanyl-up-by-1800pc/9184396.
The Guardian: Fatal fentanyl overdoses rise as Australians turn to more potent painkillers. 2017, Avialable at: https://www.theguardian.com/australia-news/2017/aug/31/fatal-fentanyl-overdoses-rise-as-australians-turn-to-more-potent-painkillers.
Google Scholar
Manchikanti L, Kaye AM, Kaye AD. Current state of opioid therapy and abuse. Curr Pain Headache Rep. 2016;20(5):34.
Article
PubMed
Google Scholar
Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis. 2008;27(1):1–11.
Article
PubMed
Google Scholar
Webster BS, Cifuentes M, Verma S, Pransky G. Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: a multilevel analysis. Am J Ind Med. 2009;52(2):162–71.
Article
PubMed
Google Scholar
Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, Mamdani M: Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthcare Quarterly (Toronto) 2011, 14(1):22–24.
Google Scholar
Brownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf. 2010;19(6):627–37.
Article
PubMed
PubMed Central
Google Scholar
The Mercury: Morphine addiction woe. Tasmanian has the nation's highest proportion of drug treatment patients seeking help for morphine Addiction. In: The Mercury Tasmania; 2014. p. 2.
Google Scholar
McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012;13(10):988–96.
Article
PubMed
PubMed Central
Google Scholar
Curtis LH, Stoddard J, Radeva JI, Hutchison S, Dans PE, Wright A, Woosley RL, Schulman KA. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Serv Res. 2006;41(3 Pt 1):837–55.
Article
PubMed
PubMed Central
Google Scholar
Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clin Ther. 2013;35(3):303–11.
Article
PubMed
PubMed Central
Google Scholar
Mapping an Opioid Addiction Community Intervention Plan. Esri Insider. Available at: https://blogs.esri.com/esri/esri-insider/2016/08/31/mapping-an-opioid-addiction-community-intervention-plan/; accessed on 4 Nov 2016.
Mazumdar S, McRae IS, Islam MM. How can geographical information systems and spatial analysis inform a response to prescription opioid misuse? A discussion in the context of existing literature. Curr Drug Abuse Rev. 2015;8(2):104–10.
Article
PubMed
Google Scholar
Blanch B, Pearson SA, Haber PS. An overview of the patterns of prescription opioid use, costs and related harms in Australia. Br J Clin Pharmacol. 2014;78(5):1159–66.
Article
PubMed
PubMed Central
Google Scholar
Islam MM, McRae IS, Mazumdar S, Taplin S, McKetin R. Prescription opioid analgesics for pain management in Australia: twenty years of dispensing. Intern Med J. 2015;46(8):955–63.
Article
Google Scholar
Degenhardt L, Gisev N, Cama E, Nielsen S, Larance B, Bruno R. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia. Pharmacoepidemiol Drug Saf. 2016;25(5):521–38.
Article
PubMed
CAS
Google Scholar
Australian Government Department of Health: The Pharmaceutical Benefit Scheme. Available at: http://www.pbs.gov.au/info/about-the-pbs; accessed on 18 August 2016.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2018. Oslo, Norway, 2017. https://www.whocc.no/filearchive/publications/guidelines.pdf.
World Health Organization: Daily Defined Dose (DDD): Definition and general considerations. Available at: https://www.whocc.no/ddd/definition_and_general_considera/; accessed on 1 December 2017.
Department of Infrastructure and Regional Development (DIRD). Local government national report, 2013–14. Canberra: DIRD; 2015. Available at http://regional.gov.au/local/publications/reports/2013_2014/INFRA2466_LGNR_2013-14.pdf.
Google Scholar
StataCorp. Stata Statistical Software: Release 14. College Station: StataCorp LP; 2015.
Google Scholar
Microsoft. Microsoft Excel [computer software]. Redmond, Washington: Microsoft; 2013.
Google Scholar
R Core Team. R: A language and environment for statistical Computing R Foundation for Statistical Computing. Vienna; 2011. Retrieved from http://www.R-project.org/.
Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016;6(6):e010364.
Article
PubMed
PubMed Central
CAS
Google Scholar
Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg. 2007;105(1):205–21.
Article
PubMed
Google Scholar
Lembke A. Why doctors prescribe opioids to patients they know are abusing them? SCOPE. Stanford Medicine. Available at: http://scopeblog.stanford.edu/2012/10/25/why-doctors-prescribe-opioids-to-patients-they-know-are-abusing-them/; accessed on 4 November 2016.
Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–7.
Article
PubMed
PubMed Central
Google Scholar
Nielsen S, Bruno R, Degenhardt L, Stoove MA, Fischer JA, Carruthers SJ, Lintzeris N. The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Med J Aust. 2013;199(10):696–9.
Article
PubMed
Google Scholar
Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195:280–4.
Article
PubMed
Google Scholar
Stafford J, Burns L. Australian Drug Trends 2012: Findings from the Illicit Drug Reporting System (IDRS). In: Australian Drug Trend Series No 91. Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2013.
Google Scholar
Black E, Roxburgh A, Degenhardt L, Bruno R, Campbell G, Bd G, Fetherston J, Kinner S, Moon C, Quinn B, et al. Australian Drug Trends 2007: Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trend Series No. 1. Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2008.
NPS Medicinewise: Oxycodone-with-naloxone controlled-release tablets (Targin) for chronic severe pain. 2011, Available at: https://www.nps.org.au/radar/articles/oxycodone-with-naloxone-controlled-release-tablets-targin-for-chronic-severe-pain.
Google Scholar
Sadowski CA, Carrie AG, Grymonpre RE, Metge CJ, St John P. Access and intensity of use of prescription analgesics among older Manitobans. Can J Clin Pharmacol. 2009;16(2):e322–30.
PubMed
Google Scholar
Simoni-Wastila L. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000;9(3):289–97.
Article
PubMed
CAS
Google Scholar
Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on drug use and health. Addict Behav. 2010;35(11):1001–7.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention: Prescription Painkiller Overdoses: A Growing Epidemic, Especially Among Women. 2017, Available at: https://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html; accessed on 18 Nov 2017.
Google Scholar
Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011;37(5):313–23.
Article
PubMed
PubMed Central
Google Scholar
Back SE, Lawson KM, Singleton LM, Brady KT. Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav. 2011;36(8):829–34.
Article
PubMed
PubMed Central
Google Scholar
Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135–45.
PubMed
PubMed Central
Google Scholar
Allin S, Laporte A. Socioeconomic status and the use of medicines in the Ontario public drug program. Canadian Public Policy. 2011;37(4):563–76.
Article
Google Scholar
Prunuske JP, St Hill CA, Hager KD, Lemieux AM, Swanoski MT, Anderson GW, Lutfiyya MN. Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data. BMC Health Serv Res. 2014;14:563.
Article
PubMed
PubMed Central
Google Scholar
Piantadosi S, Byar DP, Green SB. The ecological fallacy. Am J Epidemiol. 1988;127(5):893–904.
Article
PubMed
CAS
Google Scholar
Australian Government Department of Human Servcies. Prescription Shopping Programme. Available at: https://www.humanservices.gov.au/health-professionals/services/medicare/prescription-shopping-programme; accessed on 1 September 2016.
Islam MM, McRae IS. An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol. 2014;15(1):46.
Article
PubMed
PubMed Central
Google Scholar
Nielsen S, Bruno R. Implementing real-time prescription drug monitoring: are we ready? Drug Alcohol Rev. 2014;33(5):463–5.
Article
PubMed
Google Scholar
Ogeil RP, Heilbronn C, Lloyd B, Lubman DI. Prescription drug monitoring in Australia: capacity and coverage issues. Med J Aust. 2016;204(4):148.
Article
PubMed
Google Scholar
Islam MM, McRae IS. Real-time prescription drug monitoring program in Australia: we should be ready. Drug Alcohol Rev. 2015;34(3):344–5.
Article
PubMed
Google Scholar
Victoria State Government: Real-time prescription monitoring initiative FAQ. Available at: https://www2.health.vic.gov.au/public-health/drugs-and-poisons/real-time-prescription-monitoring. 2016.
Google Scholar
Shand FL, Campbell G, Hall W, Lintzeris N, Cohen M, Degenhardt L. Real-time monitoring of schedule 8 medicines in Australia: evaluation is essential. Med J Aust. 2013;198(2):80–1.
Article
PubMed
Google Scholar
Griggs C: 2014–2015 APhA policy committee report. Integrated Nationwide Prescription Drug Monitoring Program Available at: https://www.pharmacist.com/sites/default/files/files/Prescription%20Drug%20Monitoring%20Programs.pdf; Accesson on 26 August 2016.